A shorter screening interval does not improve the detection of aggressive prostate cancer
This article has no abstract so we have provided the first paragraph of the full text.
The introduction of PSA screening for prostate cancer has resulted in an increased incidence of this disease; however, the optimum screening interval has yet to be determined. Roobol and colleagues compared the rate of interval cancers (cancers diagnosed during the interval between screenings) in Rotterdam, The Netherlands (4-year screening interval) and Gothenburg, Sweden (2-year screening interval).
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.